Cargando…

RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression

Huntington’s Disease (HD) is a devastating neurodegenerative disorder that is caused by an expanded CAG trinucleotide repeat in the Huntingtin (HTT) gene. Transcriptional dysregulation in the human HD brain has been documented but is incompletely understood. Here we present a genome-wide analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labadorf, Adam, Hoss, Andrew G., Lagomarsino, Valentina, Latourelle, Jeanne C., Hadzi, Tiffany C., Bregu, Joli, MacDonald, Marcy E., Gusella, James F., Chen, Jiang-Fan, Akbarian, Schahram, Weng, Zhiping, Myers, Richard H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670106/ https://www.ncbi.nlm.nih.gov/pubmed/26636579 http://dx.doi.org/10.1371/journal.pone.0143563

Ejemplares similares

Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression
por: Labadorf, Adam, et al.
Publicado: (2016)

miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement
por: Hoss, Andrew G, et al.
Publicado: (2015)

MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington's Disease Pathogenesis
por: Hoss, Andrew G., et al.
Publicado: (2014)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
por: Reed, Eric R., et al.
Publicado: (2018)

The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington’s Disease
por: Dong, Xianjun, et al.
Publicado: (2015)

The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane
por: Nagle, Michael W., et al.
Publicado: (2016)

microRNA Profiles in Parkinson's Disease Prefrontal Cortex
por: Hoss, Andrew G., et al.
Publicado: (2016)

Huntington's disease: the case for genetic modifiers
por: Gusella, James F, et al.
Publicado: (2009)

Novel microRNA discovery using small RNA sequencing in post-mortem human brain
por: Wake, Christian, et al.
Publicado: (2016)

Evaluation of Parkinson Disease Risk Variants as Expression-QTLs
por: Latourelle, Jeanne C., et al.
Publicado: (2012)

Genetic analysis of the GRIK2 modifier effect in Huntington's disease
por: Zeng, Wenqi, et al.
Publicado: (2006)

Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles
por: Labadorf, Adam, et al.
Publicado: (2018)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

Coordinated Cell Type–Specific Epigenetic Remodeling in Prefrontal Cortex Begins before Birth and Continues into Early Adulthood
por: Shulha, Hennady P., et al.
Publicado: (2013)

The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington’s disease brain
por: Agus, Filisia, et al.
Publicado: (2019)

Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease
por: Dumitriu, Alexandra, et al.
Publicado: (2016)

Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation
por: Dumitriu, Alexandra, et al.
Publicado: (2012)

Evidence of Extensive Alternative Splicing in Post Mortem Human Brain HTT Transcription by mRNA Sequencing
por: Labadorf, Adam T., et al.
Publicado: (2015)

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
por: McAllister, Branduff, et al.
Publicado: (2021)

Hypomorphic mutation of the mouse Huntington’s disease gene orthologue
por: Murthy, Vidya, et al.
Publicado: (2019)

Epigenetic mechanisms in schizophrenia
por: Akbarian, Schahram
Publicado: (2014)

Metabolic disruption identified in the Huntington’s disease transgenic sheep model
por: Handley, Renee. R., et al.
Publicado: (2016)

Population-specific genetic modification of Huntington's disease in Venezuela
por: Chao, Michael J., et al.
Publicado: (2018)

Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain
por: Dumitriu, Alexandra, et al.
Publicado: (2012)

Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease
por: Ramos, Eliana Marisa, et al.
Publicado: (2015)

Use of the epigenetic toolbox to contextualize common variants associated with schizophrenia risk 
por: Rajarajan, Prashanth, et al.
Publicado: (2019)

The tRNA regulome in neurodevelopmental and neuropsychiatric disease
por: Blaze, Jennifer, et al.
Publicado: (2022)

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2013)

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2012)

GAD1 mRNA Expression and DNA Methylation in Prefrontal Cortex of Subjects with Schizophrenia
por: Huang, Hsien-Sung, et al.
Publicado: (2007)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

PMS1 as a target for splice modulation to prevent somatic CAG repeat expansion in Huntington’s disease
por: McLean, Zachariah L., et al.
Publicado: (2023)

Large-scale identification of clinical and genetic predictors of Parkinson’s disease motor progression in newly-diagnosed patients: a longitudinal cohort study and validation
por: Latourelle, Jeanne C., et al.
Publicado: (2017)

3D Genome Plasticity in Normal and Diseased Neurodevelopment
por: Plaza-Jennings, Amara, et al.
Publicado: (2022)

Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation
por: Wang, Jin, et al.
Publicado: (2005)

Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington’s disease knock-in mice is blocked by Mlh1 knock-out
por: Loupe, Jacob M, et al.
Publicado: (2020)

Chromosome substitution strain assessment of a Huntington’s disease modifier locus
por: Ramos, Eliana Marisa, et al.
Publicado: (2015)

Risk of Parkinson's disease after tamoxifen treatment
por: Latourelle, Jeanne C, et al.
Publicado: (2010)

Estrogen-related and other disease diagnoses preceding Parkinson’s disease
por: Latourelle, Jeanne C, et al.
Publicado: (2010)

A Multi-Omic Huntington’s Disease Transgenic Sheep-Model Database for Investigating Disease Pathogenesis
por: Mears, Emily R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_grt90p87tkjq006lb6jikahiaa